Back to calendar
Relmada Therapeutics, Inc. (RLMD) Earnings
RLMD reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.20
Actual EPS: $-0.22
EPS surprise: -9.81%
Company overview
Market Cap$549.6M
PriceUSD 5.24
EPS (TTM)-1.11
52-week high8.00
52-week low0.55
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees17